Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Anderes

Kenna Anderes, San Diego, CA US

Patent application numberDescriptionPublished
20080318938METHODS FOR TREATING ABERRANT CELL PROLIFERATION DISORDERS - The invention relates in part to methods for inhibiting proliferation of cancer cells and treating one or more cell proliferative conditions using compounds described herein.12-25-2008
20090312280COMBINATION THERAPY OF (2R,Z)-2-AMINO-2-CYCLOHEXYL-N-(5-(1-METHYL-1H-PYRAZOL-4-YL)-1-OXO-2,6-DIH- YDRO-1H-[1,2]DIAZEPINO[4,5,6-CD]INDOL-8-YL)ACETAMIDE - The present invention relates to novel combination therapies of (2R,Z)-2-amino-2-cyclohexyl-N-(5-(1-methyl-1H-pyrazol-4-yl)-1-oxo-2,6-dihydro -1H-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide (compound 1), a pharmaceutically acceptable salt thereof, or a mixture thereof, in combination with an anti-cancer agent or radiation therapy.12-17-2009
20100173013TREATMENT OF NEOPLASTIC DISORDERS USING COMBINATION THERAPIES - The present application is generally directed to compounds, compositions and methods of combination therapy for the treatment of neoplastic disorders.07-08-2010
20100267753METHODS OF TREATING DISORDERS ASSOCIATED WITH PROTEIN KINASE CK2 ACTIVITY - The invention provides methods for the treatment or amelioration of disorders associated with undesired activity of protein kinase CK2, using compounds of Formula (I)10-21-2010

Patent applications by Kenna Anderes, San Diego, CA US

Kenna L. Anderes, San Diego, CA US

Patent application numberDescriptionPublished
20110212845Biomarkers for predicting the sensitivity and response of protein kinase CK2-mediated diseases to CK2 Inhibitors - Disclosed are biomarkers for determining the sensitivity of protein kinase CK2-mediated diseases, such as proliferative and/or inflammatory disorders, to treatment with CK2 inhibitors. These biomarkers can be used to predict or select subjects likely to be responsive to treatment with a CK2 inhibitor, and to treat or monitor subjects undergoing treatment with a CK2 inhibitor.09-01-2011

Steve Anderes, Cupertino, CA US

Patent application numberDescriptionPublished
20080261774Seat for cardio-fitness equipment - One embodiment of the present invention discloses a cardio-fitness equipment with a seat that features height adjustment, proximity to handlebars adjustment, and easy removal of the seat for the purpose of exchange with a different user-selected model or for cleaning.10-23-2008
20090118099CLOSED-LOOP POWER DISSIPATION CONTROL FOR CARDIO-FITNESS EQUIPMENT - Various embodiments of the present invention provide (a) an inexpensive apparatus enabling the measurement of power dissipated by the rider of a cardio-fitness station (or any other stationary bicycle) that does not depend on manufacturing tolerances or machine condition variations, and (b) a method of using the data measured by such an apparatus to improve the accuracy of exercise condition settings by implementing the invented apparatus into a closed-loop control system which improves the quality of the exercise experience and enhances the adoption of exercise on a cardio-fitness station employing this as a community activity.05-07-2009

Steve Anderes, Sunnyvale, CA US

Patent application numberDescriptionPublished
20080207402Closed-Loop Power Dissipation Control For Cardio-Fitness Equipment - Various embodiments of the present invention provide (a) an inexpensive apparatus enabling the measurement of power dissipated by the rider of a cardio-fitness station (or any other stationary bicycle) that does not depend on manufacturing tolerances or machine condition variations, and (b) a method of using the data measured by such an apparatus to improve the accuracy of exercise condition settings by implementing the invented apparatus into a closed-loop control system which improves the quality of the exercise experience and enhances the adoption of exercise on a cardio-fitness station employing this as a community activity.08-28-2008